May 8, 1987
A controversial drug to treat two lethal types of cancer has won approval from the Food and Drug Administration for wider trials in humans, it was announced. An FDA spokeswoman said the agency will permit the National Cancer Institute to expand the use of interleukin-2 to a larger number of patients with advanced melanoma and kidney cancer. The treatment will be available to patients selected for participation in tests at NCI-approved cancer centers.
March 27, 1991 |
Frying, broiling and barbecuing produce potentially carcinogenic compounds in meat, chicken and fish, but microwaving, stewing and poaching do not, the National Cancer Institute said in reporting on a laboratory study. Researchers at the institute's Division of Cancer Etiology found that cooking at high temperatures and for a long time produced compounds that caused cancer in monkeys and other lab animals. Dr.
August 6, 2010
The headlines were certainly scary enough to turn readers into vegetarians: "Sausages and Bacon Up Bladder Cancer Risk" "My Bologna Has a First Name, It's C-A-N-C-E-R. " "Cold Cut Sandwiches: A Potentially Deadly Lunch. " Fortunately for meat eaters out there, the study that prompted this week's dire warnings wasn't quite as absolute as it was made to appear. For starters, studies linking red meat consumption to cancer aren't new. But this study, published online Monday by the journal Cancer, zeroed in on a specific culprit -- processed red meat -- and a particular body part -- the bladder.
February 28, 1989 |
The federal government and the American Cancer Society on Monday announced a stop-smoking drive expected to reach more than one-fifth of the U.S. population and at least 15 million smokers. The National Cancer Institute estimates it will spend $116.5 million on the project, which is being billed as "the world's largest" effort to reduce smoking.
April 26, 1989
U.S. cancer researchers announced a joint cancer study with the Soviet Union. Scientists from the National Cancer Institute in Bethesda, Md., and the Dana-Farber Cancer Institute in Boston said the study--three separate clinical trials--will be the first of its kind. It will involve carefully monitored trials of new therapies on several hundred Soviet and American patients over two years, said Dr. Emil Frei III, director of the Dana-Farber institute, which is affiliated with Harvard Medical School.